Globus Medical (GMED) PT Raised to $64 at Stifel
Tweet
Share
E-mailGet Alerts GMED Hot Sheet
Price: $85.90 --0%
Rating Summary:
22 Buy, 8 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 10 | Down: 16 | New: 19
Rating Summary:
22 Buy, 8 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 10 | Down: 16 | New: 19
Join SI Premium – FREE
Stifel analyst Mathew Blackman raised the price target on Globus Medical (NYSE: GMED) to $64.00 (from $61.00) while maintaining a Buy rating.
You May Also Be Interested In
- Aebi Schmidt Holding AG (AEBI) PT Raised to $17 at DA Davidson Following Q2 Results
- QBE Insurance Group Ltd. (QBE:AU) (QBEIF) PT Lowered to AUD26.50 at JPMorgan
- Monopar Therapeutics (MNPR) PT Raised to $130 at Morgan Stanley
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
